We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effectiveness of Aprepitant in Addition to Ondansetron in the Prevention of Nausea and Vomiting Caused by Upper Abdominal Radiotherapy (AVERT)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00970905
First Posted: September 3, 2009
Last Update Posted: December 5, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Mayo Clinic
Wake Forest University Health Sciences
Norris Cotton Cancer Center
University of Massachusetts, Worcester
Information provided by (Responsible Party):
Steven Ades, University of Vermont
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 1, 2016
  Primary Completion Date: July 1, 2016 (Final data collection date for primary outcome measure)